Search Results - "Murakami, Shigekazu"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    A Yap-Myc-Sox2-p53 Regulatory Network Dictates Metabolic Homeostasis and Differentiation in Kras-Driven Pancreatic Ductal Adenocarcinomas by Murakami, Shigekazu, Nemazanyy, Ivan, White, Shannon M., Chen, Hengye, Nguyen, Chan D.K., Graham, Garrett T., Saur, Dieter, Pende, Mario, Yi, Chunling

    Published in Developmental cell (07-10-2019)
    “…Employing inducible genetically engineered and orthotopic mouse models, we demonstrate a key role for transcriptional regulator Yap in maintenance of…”
    Get full text
    Journal Article
  2. 2

    SRY and OCT4 Are Required for the Acquisition of Cancer Stem Cell‐Like Properties and Are Potential Differentiation Therapy Targets by Murakami, Shigekazu, Ninomiya, Wataru, Sakamoto, Erina, Shibata, Tatsuhiro, Akiyama, Hirotada, Tashiro, Fumio

    Published in Stem cells (Dayton, Ohio) (01-09-2015)
    “…The acquisition of stemness is a hallmark of aggressive human hepatocellular carcinoma (hHCC). The stem cell marker OCT4 is frequently expressed in HCCs, and…”
    Get full text
    Journal Article
  3. 3

    Spontaneously evolved progenitor niches escape Yap oncogene addiction in advanced pancreatic ductal adenocarcinomas by Murakami, Shigekazu, White, Shannon M., McIntosh, Alec T., Nguyen, Chan D. K., Yi, Chunling

    Published in Nature communications (15-03-2023)
    “…Lineage plasticity has been proposed as a major source of intratumoral heterogeneity and therapeutic resistance. Here, by employing an inducible genetic…”
    Get full text
    Journal Article
  4. 4

    PRMT1 promotes epigenetic reprogramming associated with acquired chemoresistance in pancreatic cancer by Nguyen, Chan D.K., Colón-Emeric, Benjamín A., Murakami, Shigekazu, Shujath, Mia N.Y., Yi, Chunling

    Published in Cell reports (Cambridge) (28-05-2024)
    “…Pancreatic ductal adenocarcinoma (PDAC) carries a dismal prognosis due to therapeutic resistance. We show that PDAC cells undergo global epigenetic…”
    Get full text
    Journal Article
  5. 5

    SGF29 and Sry pathway in hepatocarcinogenesis by Kurabe, Nobuya, Murakami, Shigekazu, Tashiro, Fumio

    Published in World journal of biological chemistry (26-08-2015)
    “…Deregulated c-Myc expression is a hallmark of many human cancers. We have recently identified a role of mammalian homolog of yeast…”
    Get full text
    Journal Article
  6. 6

    The complex entanglement of Hippo-Yap/Taz signaling in tumor immunity by White, Shannon M., Murakami, Shigekazu, Yi, Chunling

    Published in Oncogene (01-04-2019)
    “…The Hippo-Yap/Taz pathway, originally identified as a central developmental regulator of organ size, has been found perturbed in many types of human tumors,…”
    Get full text
    Journal Article
  7. 7

    Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma by Murakami, S, Shahbazian, D, Surana, R, Zhang, W, Chen, H, Graham, G T, White, S M, Weiner, L M, Yi, C

    Published in Oncogene (02-03-2017)
    “…Pancreatic ductal adenocarcinoma (PDAC) is characterized by a high degree of inflammation and profound immune suppression. Here we identify Yes-associated…”
    Get full text
    Journal Article